Safety Study of JPH034 in Healthy Adults
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–50 years old
- Healthy with no major heart, liver, kidney, or mental health conditions
- Normal blood pressure, heart rate, and kidney function
- No recent infections, illnesses, or prescription medications (within 2 weeks)
- Not pregnant, breastfeeding, or planning pregnancy for 30 days after last dose
- Willing to follow contraception requirements and study visit schedules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests a new drug called J4 in healthy adults to see if it is safe and how the body processes it. Healthy volunteers aged 18 to 64 may join to help researchers learn about the drug's effects.
This study tests a new investigational drug called JZP047 in healthy volunteers. Researchers want to see how safe it is, how the body processes it, and whether taking it with food changes its effects.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
Hear when a new Health Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.